Packaging and Labeling - NEW!

RMC is now offering secondary GMP labeling and packaging for clinical Phase I/II materials. We've recently modified the lab to provide a dedicated packaging and labeling area with segregated working spaces. We only provide early stage secondary labeling/packaging/distribution services; therefore our costs are commensurate with this stage of development. If you're looking for a cost-effective solution to your early stage clinical product labeling needs, we can help.

We develop Project Execution Protocols specific to your needs utilizing GMP compliant documentation systems to capture all stages of the process from product receipt to final distribution
We provide kitting services for multi-component clinical product kits
We arrange shipment of your temperature controlled material to your approved clinical site
Our lab space utilizes controlled and monitored temperature conditions
We can store your materials in a segregated and secured manner under controlled and monitored conditions.
Our GMP operations are compliant with:
- Applicable Labeling and Packaging Operations requirements as described in Title 21, Part 211 of the Code of (US) Federal Regulations current Good Manufacturing Practices (21CFR211)
- Annex 13 of Volume 4 of the EU Guidelines to Good Manufacturing Practice
- EU Guidelines on Good Distribution Practice of Medicinal Products for Human Use (94/C 63/03)
Our team members have prior experience with secondary labeling/packaging/distribution of clinical trial materials within the US, Canada, Europe, and Asia.